Table 3.

Primary endpoint and clinical outcomes at 3 years according to sex and clinical presentation.

	SAP			UAP/NSTEMI			STEMI			P — SAP vs. UAP/NSTEMI vs. STEMI
	Women (n = 1932)	Men (n = 4435)	P	Women (n = 2700)	Men (n = 5490)	P	Women (n = 584)	Men (n = 2145)	P	Women	Men
All-cause death	81 (4.2%)	229 (5.2%)	0.103	166 (6.1%)	307 (5.6%)	0.313	65 (11.1%)	149 (6.9%)	0.001	< 0.001	0.010
Cardiac death	58 (3.0%)	125 (2.8%)	0.703	101 (3.7%)	177 (3.2%)	0.226	46 (7.9%)	94 (4.4%)	0.001	< 0.001	0.003
MI	11 (0.6%)	34 (0.8%)	0.384	37 (1.4%)	56 (1.0%)	0.157	9 (1.5%)	40 (1.9%)	0.650	0.016	< 0.001
Stroke	33 (1.7%)	68 (1.5%)	0.611	44 (1.6%)	72 (1.3%)	0.249	11 (1.9%)	33 (1.5%)	0.507	0.855	0.575
Stent thrombosis	7 (0.4%)	18 (0.4%)	0.801	18 (0.7%)	35 (0.6%)	0.873	7 (1.2%)	25 (1.2%)	0.924	0.059	0.001
TLR	62 (3.2%)	146 (3.3%)	0.860	90 (3.3%)	200 (3.6%)	0.486	20 (3.4%)	59 (2.8%)	0.321	0.892	0.167
TVR	71 (3.7%)	181 (4.1%)	0.440	106 (3.9%)	242 (4.4%)	0.320	24 (4.1%)	72 (3.4%)	0.307	0.761	0.136
Major bleeding	28 (1.4%)	47 (1.1%)	0.185	39 (1.4%)	59 (1.1%)	0.147	5 (0.9%)	17 (0.8%)	0.850	0.564	0.543
Minor bleeding	19 (1.0%)	41 (0.9%)	0.818	53 (2.0%)	78 (1.4%)	0.065	13 (2.2%)	25 (1.2%)	0.043	0.015	0.075

Values are number (%); p values are from the log-rank test. SAP — stable angina pectoris; UAP — unstable angina pectoris; NSTEMI — non-ST-segment elevation MI; STEMI — ST-segment elevation MI; MI — myocardial infarction; TLR — target lesion revascularization; TVR — target vessel revascularization